| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/28/2013 | CA2744756C Monocarbams and their use as antibacterial agent |
| 05/28/2013 | CA2740262C 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
| 05/28/2013 | CA2739883C Cyclohexane derivative and pharmaceutical use thereof |
| 05/28/2013 | CA2736380C Compositions comprising polymers having amino sugar units and methods of making and using same |
| 05/28/2013 | CA2735184C Heteroaryls amide derivatives and their use as glucokinase activators |
| 05/28/2013 | CA2727722C Use of dihydroimidazolones for the treatment of anxiety in dogs |
| 05/28/2013 | CA2720946C Compounds and compositions as protein kinase inhibitors |
| 05/28/2013 | CA2716994C Pharmaceutical compositions having desirable bioavailability |
| 05/28/2013 | CA2716352C Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| 05/28/2013 | CA2714295C Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/28/2013 | CA2685447C Pharmaceutical composition |
| 05/28/2013 | CA2672716C Novel therapeutic use for treating leukaemia |
| 05/28/2013 | CA2664113C Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
| 05/28/2013 | CA2656635C Stent with polymeric coating comprising rapamycin as an active agent |
| 05/28/2013 | CA2650698C Copolyvidone-containing preparation |
| 05/28/2013 | CA2648236C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/28/2013 | CA2647451C Process for the production of carotenoid compositions |
| 05/28/2013 | CA2623958C 2-heteroaryl-substituted indole derivative |
| 05/28/2013 | CA2615795C Premature ovulation preventive agent |
| 05/28/2013 | CA2604797C New tricyclic angiotensin ii agonists |
| 05/28/2013 | CA2603371C Trihydroxy polyunsaturated eicosanoid derivatives |
| 05/28/2013 | CA2599733C Methods and compositons for modified release of nutritional supplements |
| 05/28/2013 | CA2598301C Salt of proline derivative, solvate thereof, and production method thereof |
| 05/28/2013 | CA2595033C Gastroresistant pharmaceutical formulations containing rifaximin |
| 05/28/2013 | CA2592891C Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 05/28/2013 | CA2588338C Compositions comprising azelastine and methods of use thereof |
| 05/28/2013 | CA2587677C High concentration self-microemulsifying coenzyme q10 preparations for nutritional use |
| 05/28/2013 | CA2584651C Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds |
| 05/28/2013 | CA2582760C Modulators of hcv replication |
| 05/28/2013 | CA2579807C Composition with preventive or improvement effect on symptoms or diseases associated with stress-induced behavior disorders |
| 05/28/2013 | CA2577467C Hiv inhibiting 5-heterocyclyl pyrimidines |
| 05/28/2013 | CA2576765C Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 05/28/2013 | CA2573688C (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane |
| 05/28/2013 | CA2573092C Pyridodihydropyrazinones method for production and use thereof as medicaments |
| 05/28/2013 | CA2571293C 2-benzylaminodihydropteridinones, method for producing them and use thereof as drugs |
| 05/28/2013 | CA2570795C Process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt |
| 05/28/2013 | CA2570786C Modified cpg-containing oligonucleotide multimers in immune stimulation |
| 05/28/2013 | CA2565630C Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/28/2013 | CA2564592C Compositions for improving breast health in women |
| 05/28/2013 | CA2562693C Reverse-turn mimetics and method relating thereto |
| 05/28/2013 | CA2562160C Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 05/28/2013 | CA2561897C Thio-substituted biaryl-methanesulfinyl derivatives |
| 05/28/2013 | CA2561066C Antiviral 4-aminocarbonylamino-substituted imidazole compounds |
| 05/28/2013 | CA2560776C Vegetable based dioxanone derivatives, synthesis and uses thereof |
| 05/28/2013 | CA2559748C Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| 05/28/2013 | CA2559568C Materials and methods for treating coagulation disorders |
| 05/28/2013 | CA2553243C Pyrrolo pyrimidine derivatives useful for treating proliferative diseases |
| 05/28/2013 | CA2552529C Use of ribose in recovery from anaesthesia |
| 05/28/2013 | CA2551183C Process for producing pellets for pharmaceutical compositions |
| 05/28/2013 | CA2550625C Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 05/28/2013 | CA2550298C Reduction of toxicity of multi-targeting antifolates |
| 05/28/2013 | CA2550222C Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases |
| 05/28/2013 | CA2547887C Protein modifier production inhibitor |
| 05/28/2013 | CA2544107C Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| 05/28/2013 | CA2539823C Hemiasterlin derivatives and uses thereof |
| 05/28/2013 | CA2536175C Pharmaceutical compositions and method of using levodopa and carbidopa |
| 05/28/2013 | CA2535338C Substituted 1h-imidazo[4,5-c]pyridin-4-amines,1h-imidazo[4,5-c]quinolin -4-amines and 1h-imidazo[4,5-c]naphthyridin-4-amines as immune response modifiers |
| 05/28/2013 | CA2530886C Dual nk1/nk3 antagonists for treating schizophrenia |
| 05/28/2013 | CA2530385C Melt extruded controlled release oxycodone multiparticulates |
| 05/28/2013 | CA2522708C Compositions for affecting weight loss |
| 05/28/2013 | CA2521649C Composition and uses of galectin antagonists |
| 05/28/2013 | CA2514794C Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 05/28/2013 | CA2508990C Compounds and methods for the treatment or prevention of flavivirus infections |
| 05/28/2013 | CA2508621C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/28/2013 | CA2506581C Novel 2',5'-oligoadenylic acid analogues |
| 05/28/2013 | CA2500663C Enteric composition for the manufacture of soft capsule wall |
| 05/28/2013 | CA2490452C .beta.-glucan-containing fat and oil composition and novel microorganism capable of producing .beta.-glucan |
| 05/28/2013 | CA2485346C Human adam-10 inhibitors |
| 05/28/2013 | CA2477734C Suramin and derivatives thereof as topical microbicide and contraceptive |
| 05/28/2013 | CA2476935C Drug delivery system for subconjunctival administration of fine particles |
| 05/28/2013 | CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/28/2013 | CA2459769C Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 05/28/2013 | CA2455100C Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 05/28/2013 | CA2453301C Synthetic double-stranded oligonucleotides for specific inhibition of gene expression |
| 05/28/2013 | CA2448620C Vaccination against the feline immunodeficiency virus |
| 05/28/2013 | CA2443372C Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides |
| 05/28/2013 | CA2427902C Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/28/2013 | CA2427661C Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/28/2013 | CA2381468C Percutaneous absorption preparations containing melatonin receptor agonist for percutaneous treatment of sleep disorders |
| 05/28/2013 | CA2323210C Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 05/28/2013 | CA2240292C Recombinant fusion proteins to growth hormone and serum albumin |
| 05/23/2013 | WO2013075132A1 Therapeutic rna switches compositions and methods of use |
| 05/23/2013 | WO2013075084A1 Modulators of methyl modifying enzymes, compositions and uses thereof |
| 05/23/2013 | WO2013075083A1 Modulators of methyl modifying enzymes, compositions and uses thereof |
| 05/23/2013 | WO2013075035A1 Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases |
| 05/23/2013 | WO2013075029A1 Condensed imidazolylimidazoles as antiviral compounds |
| 05/23/2013 | WO2013075015A1 Methods of treatment with deferiprone |
| 05/23/2013 | WO2013074988A1 Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations |
| 05/23/2013 | WO2013074986A1 Inhibitors of c-jun-n-terminal kinase (jnk) |
| 05/23/2013 | WO2013074930A1 Methods for treating leishmaniasis |
| 05/23/2013 | WO2013074910A1 Glucagon superfamily peptides exhibiting glucocorticoid receptor activity |
| 05/23/2013 | WO2013074906A1 Compositions for controlling food intake and uses therefor |
| 05/23/2013 | WO2013074905A2 Compounds, compositions, pharmaceutical compositions, and methods of use |
| 05/23/2013 | WO2013074892A1 Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof |
| 05/23/2013 | WO2013074889A1 Methods of treating and preventing leukemia and other cancers of the blood and bone |
| 05/23/2013 | WO2013074860A1 Polymeric colorant compositions and methods of use |
| 05/23/2013 | WO2013074817A1 Solid state forms of linagliptin |
| 05/23/2013 | WO2013074648A1 Methods of preparing progesterone pharmaceutical compositions |
| 05/23/2013 | WO2013074641A1 Piperidinyl- substituted cyclic ureas as gpr119 modulators |
| 05/23/2013 | WO2013074633A1 Uracil derivatives as axl and c-met kinase inhibitors |